Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

Isamu Okamoto, Moritaka Suga

Research output: Contribution to journal › Editorial

3 Citations (Scopus)

Original language	English
Pages (from-to)	926-927
Number of pages	2
Journal	Internal Medicine
Volume	42
Issue number	10
DOIs	https://doi.org/10.2169/internalmedicine.42.926
Publication status	Published - Oct 2003
Externally published	Yes

Fingerprint

All Science Journal Classification (ASJC) codes

Internal Medicine

Cite this

Okamoto, I., & Suga, M. (2003). Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer? Internal Medicine, 42(10), 926-927. https://doi.org/10.2169/internalmedicine.42.926

@article{6b4fc2b9ffc2413aaea1f0c5a3022fac,

title = "Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?",

author = "Isamu Okamoto and Moritaka Suga",

year = "2003",

month = "10",

doi = "10.2169/internalmedicine.42.926",

language = "English",

volume = "42",

pages = "926--927",

journal = "Internal Medicine",

issn = "0918-2918",

publisher = "Japanese Society of Internal Medicine",

number = "10",

}

TY - JOUR

T1 - Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

AU - Okamoto, Isamu

AU - Suga, Moritaka

PY - 2003/10

Y1 - 2003/10

UR - http://www.scopus.com/inward/record.url?scp=0242606878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242606878&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.42.926

DO - 10.2169/internalmedicine.42.926

M3 - Editorial

C2 - 14606701

AN - SCOPUS:0242606878

VL - 42

SP - 926

EP - 927

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 10

ER -

Access to Document

10.2169/internalmedicine.42.926